Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories, Inc. expected to post earnings of 3 cents a share - Earnings Preview

Mesa Laboratories, Inc. <MLAB.OQ> expected to post earnings of 3 cents a share - Earnings Preview 
  • Mesa Laboratories, Inc. MLAB.OQ MLAB.O is expected to show a rise in quarterly revenue when it reports results on August 10 for the period ending June 30 2026

  • The Lakewood Colorado-based company is expected to report a 2.2% increase in revenue to $60.867 million from $59.54 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Mesa Laboratories, Inc. is for earnings of 3 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had fallen by about 10.5% in the last three months. ​

  • Wall Street's median 12-month price target for Mesa Laboratories, Inc. is $112.00, about 10.9% above its last closing price of $101.01

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2026

0.21

0.34

-0.75

Missed

-320.6

Dec. 31 2026

0.28

0.28

0.65

Beat

134.9

Sep. 30 2025

0.19

0.16

0.45

Beat

181.3​

Jun. 30 2025

0.45

0.44

0.85

Beat

94.7

​​Mar. 31 2025

0.99

1.09

-1.31

Missed

-220.2

Dec. 31 2024

1.77

1.75

-0.26

Missed

-114.7​

Sep. 30 2024

1.38

1.38

0.80

Missed

-42.2

Jun. 30 2024

0.39

0.44

0.84

Beat

89.5

This summary was machine generated August 7 at 21:28 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Mesa Laboratories

See all news